CIK: 0001911010
Total reported value
$616.4M
Reporting period: 2024-12-31 · Number of holdings: 15
Nextech Invest Ltd. disclosed 15 holdings in its latest 13F filing for the period ending 2024-12-31, with total reported value of $616.4M and a quarterly turnover rate of 0.0%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "N"
Nextech Invest Ltd.'s disclosed holdings carry a Herfindahl concentration index of 0.314 — mathematically equivalent to about 3 equally-sized positions, well below its 15 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes vary widely across the portfolio (a coefficient of variation of 1.99), with a handful of outsized bets alongside many smaller positions.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 54% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
No holding changes this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines INC | Stock-Healthcare | 53.94% | — | +20.71% | |
| 2 | TYRA | Tyra Biosciences INC | Stock-Other | 9.15% | — | — | |
| 3 | ORIC | Oric Pharmaceuticals INC | Stock-Other | 6.92% | — | — | |
| 4 | CRGX | Cargo Therapeutics INC | Stock-Other | 6.18% | — | — | |
| 5 | ARVN | Arvinas INC | Stock-Other | 4.38% | — | — | |
| 6 | ✓ | Mersana Therapeutics INC | Stock-Other | 2.80% | — | — | |
| 7 | TNGX | Tango Therapeutics INC | Stock-Other | 2.77% | — | — | |
| 8 | ZYME | Zymeworks INC | Stock-Other | 2.65% | — | — | |
| 9 | RLAY | Relay Therapeutics INC | Stock-Other | 2.57% | — | — | |
| 10 | CGEM | Cullinan Therapeutics INC | Stock-Other | 2.25% | — | — | |
| 11 | ALMS | Alumis INC | Stock-Other | 1.88% | — | — | |
| 12 | SPRY | Ars Pharmaceuticals INC | Stock-Other | 1.60% | — | -15.84% | |
| 13 | CNTX | Context Therapeutics INC | Stock-Other | 1.26% | — | — | |
| 14 | SLN | Silence Therapeutics Plc-adr | Stock-Other | 1.06% | — | — | |
| 15 | BOLD | Boundless Bio INC | Stock-Other | 0.58% | — | — |
Performance for Q3 2026
+23%
Performance Last 4 Quarters
+329.7%
Based on 76% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2024-12-31 | 15 | $616.4M | 0 | |
| 2024-09-30 | 15 | $712.3M | 0 | |
| 2024-06-30 | 13 | $594.5M | 0 | |
| 2024-03-31 | 12 | $630.8M | 0 | |
| 2023-12-31 | 11 | $536.8M | 0 | |
| 2023-09-30 | 14 | $330.0M | 0 | |
| 2023-06-30 | 13 | $294.2M | 0 | |
| 2023-03-31 | 12 | $239.6M | 0 | |
| 2022-12-31 | 14 | $251.4M | 0 | |
| 2022-09-30 | 14 | $309.6M | 0 | |
| 2022-06-30 | 14 | $296.5M | 0 | |
| 2022-03-31 | 14 | $350.3M | 0 | |
| 2021-12-31 | 11 | $379.6M | 0 |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-15 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-14 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-14 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-14 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-12 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-14 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-01 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-16 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-05-16 | Amendment | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001541897
Total reported value
$616.4M
898 stks
2023-06-30
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0001556846
Total reported value
$616.5M
56 stks
2015-09-30
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0001805250
Total reported value
$616.7M
144 stks
2026-03-31
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0001595430
Total reported value
$1.4B
17 stks
2026-03-31
3 of the top 5 holdings overlap, including Revolution Medicines INC
CIK 0000078003
Total reported value
$238.8M
21 stks
2026-03-31
2 of the top 5 holdings overlap, including Oric Pharmaceuticals INC
CIK 0001833486
Total reported value
$100.7M
3 stks
2026-03-31
2 of the top 5 holdings overlap, including Oric Pharmaceuticals INC